Last $49.61 USD
Change Today +1.99 / 4.18%
Volume 1.7M
ALKS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 10/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael J. Landine

Senior Vice President of Corporate Development, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 12 board members in 2 different organizations across 4 different industries.

See Board Relationships
60--

Background*

Mr. Michael J. Landine, also known as Mike, is the Founder of Genomics Collaborative, Inc. Mr. Landine has been the Senior Vice President of Corporate Development of Alkermes plc (alternate name: Alkermes, Inc) since May 22, 2007. He serves as an Advisor of Walker Magnetics Group. He served as Vice President of Corporate Development of Alkermes, Inc. from March 1999 to May 22, 2007. From March 1988 to June 1998, Mr. Landine served as Chief Financial Officer and Treasurer ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 772 8000
Fax: --

Board Members Memberships*

Founder and Director
Director
2003-Present
Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
2004-2010
Former Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee

Education*

BS
Bentley University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALKS:US $49.61 USD +1.99

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$916.2K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
--
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$867.5K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.